Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Chugai

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Chugai's Japan sales performance.

Lilly scores FDA okay for Cyramza in liver cancer

Lilly scores FDA okay for Cyramza in liver cancer Lilly has also filed for approval of Cyramza in AFP-high HCC in the EU and Japan.

Orphan drugs and breakthrough therapies drive Cortellis Drugs to Watch 2019

Orphan drugs and breakthrough therapies drive Cortellis Drugs to Watch 2019 In the EU and Japan, approval of the drug is pending, following acceptance of regulatory filings in 2018. ... In May last year, approval for Skyrizi was filed in Japan for plaque psoriasis, psoriatic arthritis, pustular psoriasis and erythrodermic

Lynparza could soon add first line ovarian use in Europe

Lynparza could soon add first line ovarian use in Europe The recommendation is based on the SOLO-1 trial in first-line BRCA-mutant ovarian cancer, with similar approvals expected soon in Japan and China, with US approval already secured.

Oncology drives AstraZeneca, Genzyme boosts Sanofi

Oncology drives AstraZeneca, Genzyme boosts Sanofi AZ confirmed it will continue to drive oncology advancements, citing its recent partnership with Japan-based pharma group Daiichi Sankyo.

Sobi shows strong growth despite haemophilia competition

Sobi shows strong growth despite haemophilia competition countries. Marketing rights to the drugs in the US, Canada and Japan are held by Bioverativ, which was acquired last year by Sanofi.

[ Previous 5 results ] 13 14 15 16 17 18 19 20 21 22 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Frontera Group

Welcome to Frontera Group, where our agencies immerse you in the world of the patient...

Latest intelligence

What challenges still face clinical trial recruitment and retention?
Discover the reasons for the current clinical trial recruitment challenges facing pharma and the life sciences industry, and how the search for solutions to the problem continues...
“Fake News” and Credibility in Medical Publishing
Natalie Yeadon from Impetus Digital shares her thoughts on fighting fake news in Pharma and healthcare....
Delivering true value: what does it mean for KAM in cancer care?
Lisa Alderson, Business Development Director at Wilmington Healthcare, explores the challenges that pharma’s KAM teams face in engaging with the NHS and how they must evolve...

Infographics